Screening for high risk human papillomavirus (HR-HPV) infection works well in practice and is more sensitive than cytology (smear) testing—offering greater protection against cervical cancer, confirm researchers in The BMJ today. Their findings therefore support a switch to HPV screening across England and provide reassurance that screening intervals could be safely extended to at least